Showing promise in the landscape of obesity therapy, retatrutide presents a unique strategy. Unlike many existing medications, retatrutide works as a twin agonist, concurrently targeting both GLP-like peptide-1 (GLP-1) https://emiliesluw521272.blog4youth.com/39225276/this-novel-retatrutide-a-glp-and-gip-binding-site-agonist